STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s peer reviewers.
DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported relevant financial relationships:
Anne L. Peters, MD, has served as an advisory board member for Abbott Diabetes Care, Medscape, Novo Nordisk, Vertex, and Zealand and as a consultant for Blue Circle Health. She has received research support from Dexcom, Insulet, and Abbott Diabetes Care. She has stock options in Omada Health and Teladoc.
E. Michael Lewiecki, MD, has received Institutional research grants from Amgen, Radius, Ultragenyx, and Angitia, has served as a consultant for Amgen, Radius, Kyowa Kirin, Angitia, and Ascendis, and has been a speaker for Amgen, Radius, Ascendis, and Kyowa Kirin.
Elizabeth McAninch, MD, serves as a consultant for Acella Pharmaceuticals and AbbVie Inc. She is a co-founder of Equilibrate Therapeutics LLC.
Hans K. Ghayee, DO, serves as a consultant for Corcept.
John D. Carmichael, MD, has served as an advisory board member for Camurus, Novo Nordisk, Recordati, and Xeris. He is also a member of the American Association of Clinical Endocrinologists (Pituitary, Adrenal, Gonad, and Neuroendocrine Disease State Network) and the Pituitary Society.
Kaniksha Desai, MD, is a member of American Thyroid Association and is on the annual program committee. She is a member of the American Association of Clinical Endocrinologists and the Thyroid Disease State Network. She is a host on “The Thyroid Stimulating Podcast” on Medscape.
Marie E. McDonnell, MD, has served as a trial event adjudicator for a trial conducted by Eisai and receives research funding from Lilly, Inc, that is paid to her institution.
Sangeeta R. Kashyap, MD, has served as a consultant and coinvestigator to GI Dynamics; she has received research support from Fractyl, Inc; and she is chief medical officer of Gila Therapeutics.
Stephanie Page, MD, PhD, is an editor at UpToDate and has served as a consultant for Pharmajor International.
The following faculty reported no relevant financial relationships: Margaret Flynn Lippincott, MD
The medical editor for this activity reported no relevant financial relationships: Abbie L. Young, MS, CGC, ELS(D)
Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
The activity is not supported by educational grant(s) or other funds from any commercial supporters.